Growth Metrics

Biogen (BIIB) Total Non-Current Liabilities (2016 - 2025)

Biogen (BIIB) has 17 years of Total Non-Current Liabilities data on record, last reported at $10.4 billion in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 1.57% year-over-year to $10.4 billion; the TTM value through Dec 2025 reached $10.4 billion, down 1.57%, while the annual FY2025 figure was $10.4 billion, 1.57% down from the prior year.
  • Total Non-Current Liabilities reached $10.4 billion in Q4 2025 per BIIB's latest filing, up from $9.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $12.1 billion in Q2 2022 and bottomed at -$1.3 billion in Q3 2021.
  • Average Total Non-Current Liabilities over 5 years is $9.4 billion, with a median of $10.6 billion recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: soared 926.07% in 2022, then tumbled 106.87% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $11.6 billion in 2021, then decreased by 11.86% to $10.2 billion in 2022, then increased by 10.2% to $11.3 billion in 2023, then fell by 5.89% to $10.6 billion in 2024, then decreased by 1.57% to $10.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $10.4 billion in Q4 2025, $9.9 billion in Q2 2025, and $10.6 billion in Q4 2024.